These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3659219)

  • 1. Platelet monoamine oxidase activity in panic disorder.
    Balon R; Rainey JM; Pohl R; Yeragani VK; Oxenkrug GF; McCauley RB
    Psychiatry Res; 1987 Sep; 22(1):37-41. PubMed ID: 3659219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kinetic analysis of platelet monoamine oxidase activity in patients with panic attacks.
    Norman TR; Acevedo A; McIntyre IM; Judd FK; Burrows GD
    J Affect Disord; 1988; 15(2):127-30. PubMed ID: 2975682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet monoamine oxidase activity in patients with panic disorder.
    Gorman J; Liebowitz MR; Fyer AJ; Levitt M; Baron M; Davies S; Klein DF
    Biol Psychiatry; 1985 Aug; 20(8):852-7. PubMed ID: 4027301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the catabolism of trace amines in mentally disordered individuals with particular reference to agoraphobic patients with panic attacks.
    Yu PH; Bowen RC; Davis BA; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):611-5. PubMed ID: 6686698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet monoamine oxidase activity and trace acid levels in plasma of agoraphobic patients.
    Yu PH; Bowen RC; Davis BA; Boulton AA
    Acta Psychiatr Scand; 1983 Mar; 67(3):188-94. PubMed ID: 6858713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet MAO-B activity in anxiety and depression.
    Khan A; Lee E; Dager S; Hyde T; Raisys V; Avery D; Dunner D
    Biol Psychiatry; 1986 Jul; 21(8-9):847-9. PubMed ID: 3730465
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet serotonin uptake in panic disorder.
    Norman TR; Judd FK; Gregory M; James RH; Kimber NM; McIntyre IM; Burrows GD
    J Affect Disord; 1986; 11(1):69-72. PubMed ID: 2944930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet [3H]imipramine binding in patients with panic disorder.
    Uhde TW; Berrettini WH; Roy-Byrne PP; Boulenger JP; Post RM
    Biol Psychiatry; 1987 Jan; 22(1):52-8. PubMed ID: 3790640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panic disorder and agoraphobia. An update for primary care physicians.
    Anixter WL
    N C Med J; 1988 Oct; 49(10):507-11. PubMed ID: 3054568
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet MAO activity: relationships to clinical and psychometric variables.
    Adler SA; Gottesman II; Orsulak PJ; Kizuka PP; Schildkraut JJ
    Schizophr Bull; 1980; 6(2):226-31. PubMed ID: 7375854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases].
    Cottraux J; Claustrat B
    Encephale; 1984; 10(6):267-72. PubMed ID: 6529933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social-evaluative anxiety in panic disorder and agoraphobia.
    Pollard CA; Cox GL
    Psychol Rep; 1988 Feb; 62(1):323-6. PubMed ID: 3363071
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine oxidase, monoamine oxidase inhibitors, and panic disorder.
    Norman TR; Burrows GD
    J Neural Transm Suppl; 1989; 28():53-63. PubMed ID: 2677243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity platelet [3H]LSD binding is decreased in panic disorder.
    Norman TR; Judd FK; Staikos V; Burrows GD; McIntyre IM
    J Affect Disord; 1990 Jun; 19(2):119-23. PubMed ID: 2142698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology.
    Whitfield JB; Pang D; Bucholz KK; Madden PA; Heath AC; Statham DJ; Martin NG
    Psychol Med; 2000 Mar; 30(2):443-54. PubMed ID: 10824664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative symptomatology of phobic and nonphobic panic attacks.
    Katerndahl DA; Gabel LL; Monk JS
    Fam Pract Res J; 1986; 6(2):106-13. PubMed ID: 3455111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrete dimensions in agoraphobia: a factor analytic study.
    Hamann MS; Mavissakalian M
    Br J Clin Psychol; 1988 May; 27(2):137-44. PubMed ID: 3395736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of separation anxiety in patients with panic disorder and depression and normal controls.
    Yeragani VK; Meiri PC; Balon R; Patel H; Pohl R
    Acta Psychiatr Scand; 1989 Jun; 79(6):550-6. PubMed ID: 2763851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.